Neonatal Sepsis, Late-Onset: Clinical Trials

6 trials for Neonatal Sepsis, Late-Onset, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed, 1 not yet recruiting. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Recruiting 1
Phase 41Active not recruiting 1

Follow Neonatal Sepsis, Late-Onset: new trials by email Literature Review of Neonatal Sepsis, Late-Onset trials Research Report on Neonatal Sepsis, Late-Onset

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neonatal Catheter Lock for Infection Prevention
Taurolidine 2% lock, Normal saline lock - CLABSI - Central Line Associated Bloodstream Infection, CRBSI - Catheter Related Bloodstream Infection
Not applicableNot yet recruitingUniversity of Turin, Italy5762026-10-012026-05-13
Vancomycin Reduction Practices (VRP) in the NICU
External Facilitation - Antibiotic Stewardship, Neonatal Sepsis, Late-Onset
Not applicableRecruitingChildren's Hospital of Philadelphia132025-06-022026-09-24
Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial
Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days, Vasoactive drug therapies - Shock, Preterm Birth Complication
Phase 4Active not recruitingCoordinación de Investigación en Salud, Mexico762025-02-012025-11-25
Amniotic Fluid & the Preterm Gut
Chorioamnionitis, Chorioamnionitis Affecting Fetus or Newborn
RecruitingMaxima Medical Center2752024-10-142025-09-03
Molecular Culture for the Diagnosis of Neonatal Sepsis
Molecular Culture - Neonatal Sepsis, Early-Onset, Culture Positive Neonatal Sepsis
UnknownJip Groen20002023-07-152023-07-24
Population Pharmacokinetics of Amikacin in Neonates
Amikacin Sulfate Injection - Neonatal Sepsis, Late-Onset
CompletedPontificia Universidad Catolica de Chile1382019-12-012022-04-07

Narrower conditions

Neonatal Sepsis (6)  ·  Chorioamnionitis (1)  ·  Communicable Diseases (1)  ·  Enterocolitis, Necrotizing (1)  ·  Fetal Growth Retardation (1)  ·  Hyperglycemia (1)  ·  Hyperphagia (1)  ·  Intestinal Perforation (1)  ·  Pulmonary Atelectasis (1)  ·  Shock (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Infant, Newborn, Diseases (6)  ·  Infections (6)  ·  Inflammation (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Sepsis (6)  ·  Systemic Inflammatory Response Syndrome (6)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Enterocolitis (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fetal Diseases (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Gastroenteritis (1)

Interventions

Amikacin (1)

Sponsors

Children's Hospital of Philadelphia (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Jip Groen (1)  ·  Maxima Medical Center (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  University of Turin, Italy (1)

Countries

Netherlands (2)  ·  Chile (1)  ·  Italy (1)  ·  Mexico (1)  ·  United States (1)

Top investigators

Alessandra Coscia, MD PhD (1)  ·  Elena Maggiora, MD (1)  ·  Francesco Cresi, MD PhD (1)  ·  Giulia Maiocco, MD (1)  ·  Nicolas F Severino, PharmD (1)  ·  Sagori Mukhopadhyay, MD, MMSc (1)  ·  Tim GJ de Meij, MD, PhD (1)

Results publications

PMID 26909227, PMID 27658190, PMID 35359891, PMID 41602874